ArticleGlobal implementation research and applications2025
Healthcare Providers' Perspectives Regarding Barriers and Facilitators to Former Pap/VIA-Based Screen-and-Treat Program in Iquitos, Peru.
Article in Global implementation research and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Screen-and-treat: a sustainable solution for cervical cancer elimination in low and middle income countries.BMJ oncology · 2026Review
- Political determinants of cervical cancer control in Peru.BMC health services research · 2025Article
- A realist evaluation of a novel cervical cancer prevention strategy in Iquitos, Peru.PLOS global public health · 2025Article
Corrections and comments
- Update of
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Longstanding structural barriers to Pap smear-based cervical cancer screening and treatment have existed in Peru for decades. The objective of this study was to understand healthcare providers' perspectives regarding the facilitators of and barriers to the now former Pap/Visual Inspection with Acetic Acid-based cervical cancer prevention program in Iquitos, Peru, to inform the transition to the human papillomavirus (HPV) molecular testing-based screen-and-treat intervention to increase screening and completion of care. We used constructs from the Consolidated Framework for Implementation Research's Inner Setting domain to understand the strengths and failures of the former system and leverage this knowledge to enhance the new HPV-based intervention's implementation. We conducted 19 semi-structured interviews with health professionals (12 nurse-midwives, 4 doctors, and 3 laboratory technicians) who administered the former Pap smear-based cervical cancer early detection and treatment program. Providers identified information gaps between the primary level of care, where cervical cancer screening occurs, and the hospital level of care, where diagnosis and treatment occurs. These gaps, caused in part by fragmented and overlapping data systems that do not connect with one another, as well as by healthcare professionals tending to concentrate solely on their own specific role, rather than recognizing the importance of all components working cohesively to facilitate completion of the continuum of care, resulted in the loss of patients between levels of care. Participants also noted a lack of trained personnel and basic materials. Some providers found their way around these gaps by facilitating informal information exchanges among providers to ensure women were not lost to follow-up. Proyecto Precáncer leveraged these findings by collaborating with stakeholders to map the former system, reach stakeholder consensus on system inefficiencies, and design an intervention that improved system efficiencies through a patient-centered approach. Supplementary Information: The online version contains supplementary material available at 10.1007/s43477-025-00164-8.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.